159 related articles for article (PubMed ID: 18311655)
1. Drug Delivery Systems--9th US-Japan symposium.
Uhland S
IDrugs; 2008 Mar; 11(3):186-8. PubMed ID: 18311655
[No Abstract] [Full Text] [Related]
2. Recent Advances in Polymeric Implants.
Ahmed KK; Tamer MA; Ghareeb MM; Salem AK
AAPS PharmSciTech; 2019 Sep; 20(7):300. PubMed ID: 31482251
[TBL] [Abstract][Full Text] [Related]
3. Applying advanced delivery technologies to enable and improve drug development. 8-9 December 2004, London, UK.
Uchegbu IF
IDrugs; 2005 Feb; 8(2):112-4. PubMed ID: 15696410
[No Abstract] [Full Text] [Related]
4. MEMS fabricated chip for an implantable drug delivery device.
Sbiaa Z
Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():5621-4. PubMed ID: 17947154
[TBL] [Abstract][Full Text] [Related]
5. The impact of systems approaches on biological problems in drug discovery.
Hood L; Perlmutter RM
Nat Biotechnol; 2004 Oct; 22(10):1215-7. PubMed ID: 15470453
[No Abstract] [Full Text] [Related]
6. Perspective from the founding editors. Preface.
Juliano R; Poste G; Tomlinson E
Adv Drug Deliv Rev; 2013 Jan; 65(1):3-4. PubMed ID: 22940253
[No Abstract] [Full Text] [Related]
7. Drug Delivery 2007--New technologies, partnering and strategies for the future.
Stevenson L
IDrugs; 2007 Jun; 10(6):388-90. PubMed ID: 17642001
[No Abstract] [Full Text] [Related]
8. Value of novelty?
Ma P; Zemmel R
Nat Rev Drug Discov; 2002 Aug; 1(8):571-2. PubMed ID: 12402497
[No Abstract] [Full Text] [Related]
9. Chemical biology and drug design: three-dimensional, dynamic, and mechanistic nature of two multidisciplinary fields.
Sawyer TK
Chem Biol Drug Des; 2006 Mar; 67(3):196-200. PubMed ID: 16611212
[No Abstract] [Full Text] [Related]
10. Anti-infectives in the 21st century.
Clough J
Drug Discov Today; 2002 Oct; 7(20):1036-8. PubMed ID: 12546891
[No Abstract] [Full Text] [Related]
11. Micro- and nano-fabricated implantable drug-delivery systems: current state and future perspectives.
Meng E; Sheybani R
Ther Deliv; 2014 Nov; 5(11):1167-70. PubMed ID: 25491666
[No Abstract] [Full Text] [Related]
12. Cancer nanotechnology: small, but heading for the big time.
Nat Rev Drug Discov; 2007 Mar; 6(3):174-5. PubMed ID: 17396287
[No Abstract] [Full Text] [Related]
13. When drugs development meets genomics.
Leung YF; Lam DS; Pang CP
Pharmacogenomics J; 2001; 1(4):237-8. PubMed ID: 11908765
[No Abstract] [Full Text] [Related]
14. Molecular targets and cancer therapeutics.
Westwell AD
Drug Discov Today; 2004 Dec; 9(24):1042-4. PubMed ID: 15582792
[No Abstract] [Full Text] [Related]
15. The journal of pharmacy and pharmacology 2008.
Jones DS
J Pharm Pharmacol; 2009 Jan; 61(1):1-2. PubMed ID: 19126290
[No Abstract] [Full Text] [Related]
16. 9th International drug delivery technologies & deal-making summit.
Panzner S; Smith PL
Expert Opin Drug Deliv; 2005 Jan; 2(1):189-90. PubMed ID: 16296745
[TBL] [Abstract][Full Text] [Related]
17. Seeing is believing--visualizing drug delivery in vitro and in vivo.
Swartz H
Adv Drug Deliv Rev; 2005 Jun; 57(8):1085-6. PubMed ID: 15935867
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical prospects for RNA interference.
Schiffelers RM; Woodle MC; Scaria P
Pharm Res; 2004 Jan; 21(1):1-7. PubMed ID: 14984251
[TBL] [Abstract][Full Text] [Related]
19. Drug Discovery Technology 2003--seventh annual conference and exhibition. Science, business and IT for drug discovery II. 31 March-3 April 2003, Stuttgart, Germany.
Mackonochie M
IDrugs; 2003 May; 6(5):420-2. PubMed ID: 12841200
[No Abstract] [Full Text] [Related]
20. The critical need for cancer biometrics: quantitative, reproducible measures of cancer to define response to therapy.
Lotze MT
Curr Opin Investig Drugs; 2003 Jun; 4(6):649-51. PubMed ID: 12901221
[No Abstract] [Full Text] [Related]
[Next] [New Search]
